Company news
Doseology Sciences, Inc. news in 2026
Doseology Sciences, Inc.'s news releases, calls and decks from 2026, newest first.
Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements
October 29, 2026
Doseology Announces Resignation of Director
October 14, 2026
Doseology Announces Director and Officer Changes; Completes Shares-for-Debt Settlement
September 30, 2026
Doseology Announces Proposed Shares-for-Debt Settlement and Resignation of Director
September 23, 2026
Doseology Announces Extension to Closing of Private Placement
June 29, 2026
Doseology Announces Extension to Closing of Private Placement and Resignation of Officer
May 15, 2026
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform
March 30, 2026
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
March 11, 2026
Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
March 4, 2026
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
February 20, 2026
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed that Brain(R) Enters Oral Stimulant Format
January 22, 2026
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format
January 21, 2026
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
January 19, 2026
Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors
January 16, 2026
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
January 12, 2026